Rare Tumors of the Colorectal Region
- Immunotherapy and targeted therapy represent innovative medical therapies to improve survival in anorectal melanoma. Pembrolizumab is a PD-1 inhibitor used as immunotherapy in melanoma.
- Clinical trials are under way examining medical therapy options in imatinib-resistant GISTs.
- Safety and effectiveness of transanal minimally invasive surgery are being studied for rectal GISTs.